tm
Seeing Is Believing
tm
Seeing Is Believing
CNTX is currently covered by 3 analysts with an average price target of $7. This is a potential upside of $6.69 (2158.06%) from yesterday's end of day stock price of $0.31.
Context Therapeutics's activity chart (see below) currently has 20 price targets and 28 ratings on display. The stock rating distribution of CNTX is 100% BUY.
Highest price target for CNTX is $9, Lowest price target is $5, average price target is $7.
Most recent stock forecast was given by BIREN AMIN from PIPER SANDLER on 24-Mar-2026. First documented stock forecast 02-Feb-2022.
Currently out of the existing stock ratings of CNTX, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Jun-2025
$7
$5.61 (403.60%)
$4
6 months 11 days ago
(24-Mar-2026)
0/2 (0%)
$3.82 (120.13%)
Buy Since 16-Oct-2025
$9
$6.39 (244.83%)
$9
10 months 28 days ago
(06-Nov-2025)
0/2 (0%)
$7.93 (741.12%)
Buy Since 09-May-2024
$5
$3.61 (259.71%)
10 months 29 days ago
(06-Nov-2025)
0/10 (0%)
$3.93 (367.29%)
Buy Since 08-Jan-2025
$4
$2.61 (187.77%)
$4
1 years 6 months 11 days ago
(24-Mar-2025)
0/2 (0%)
$3.24 (426.32%)
Buy Since 16-May-2024
$4.5
$3.11 (223.74%)
$4.5
2 years 8 days ago
(27-Sep-2024)
0/4 (0%)
$2.64 (141.94%)
Which analyst most recently updated their price target on CNTX (Context Therapeutics)?
Which analyst has the current lower performing score on CNTX (Context Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CNTX (Context Therapeutics)?
Which analyst is the currently most bullish on CNTX (Context Therapeutics)?
Which analyst is the currently most reserved on CNTX (Context Therapeutics)?
